Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

LEUCOVORIN CALCIUM 25 MG TAB

LEUCOVORIN CALCIUM
$2.0010per EA

Strength

25 mg/1

Manufacturer

Leading Pharma, LLC

NDC

69315018725

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

LEUCOVORIN CALCIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA213929

On Market Since

11/16/2020

Pharmacological Classes

Folate Analog
Folic Acid

Price History

1W

0.0%

1M

-15.1%

3M

-39.7%

6M

-4.2%

1Y

-37.8%

3Y

-56.1%

5Y

N/A

All

-64.2%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

LEUCOVORIN CALCIUM 5 MG TAB
Generic
00054449613•Hikma Pharmaceuticals USA Inc.
$0.3859
per EA
LEUCOVORIN CALCIUM 5 MG TAB
Generic
00054449625•Hikma Pharmaceuticals USA Inc.
$0.3859
per EA
LEUCOVORIN CALCIUM 5 MG TAB
Generic
00054849619•Hikma Pharmaceuticals USA Inc.
$0.3859
per EA
LEUCOVORIN CALCIUM 5 MG TAB
Generic
00555048401•Teva Pharmaceuticals USA Inc.
$0.3859
per EA
LEUCOVORIN CALCIUM 5 MG TAB
Generic
00555048402•Teva Pharmaceuticals USA Inc.
$0.3859
per EA
LEUCOVORIN CALCIUM 5 MG TAB
Generic
42806035801•Epic Pharma LLC
$0.3859
per EA
LEUCOVORIN CALCIUM 5 MG TAB
Generic
42806035830•Epic Pharma LLC
$0.3859
per EA
LEUCOVORIN CALCIUM 5 MG TAB
Generic
50742018101•Ingenus Pharmaceuticals LLC
$0.3859
per EA
LEUCOVORIN CALCIUM 5 MG TAB
Generic
50742018130•Ingenus Pharmaceuticals LLC
$0.3859
per EA
LEUCOVORIN CALCIUM 15 MG TAB
Generic
00054449810•Hikma Pharmaceuticals USA Inc.
$1.9569
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy